Latin American companies have started to return to the US IPO market, and Mexican airline Grupo Aeromexico (AERO) is set to continue the trend.The global airline filed last week for a $300 million US IPO that could come as soon as......read more
US IPO Market's Green Shoots Take Root In the first quarter of 2024, the IPO market's green shoots grew further, with 30 IPOs raising a combined $7.8 billion. While deal count was in line with the 1Q23, proceeds more than tripled, thanks to the continued return ...read more
In February, 10 IPOs raised a combined $2.0 billion, led by early debuts from a handful of $100+ million offerings. Deal flow was led by healthcare and senior facilities provider American Healthcare REIT (AHR) and Mexican discount grocer BBB Foods (TBBB),...read more
Six IPOs priced this past week, joined by two blank check companies.One larger deal did not get done: Fortegra (TFG) pulled its $297 million offering ahead of its expected pricing. The specialty insurer had previously attempted to go public in early 2021 but...read more
Latin America's return to the US IPO market continues with Aeromexico
Latin American companies have started to return to the US IPO market, and Mexican airline Grupo Aeromexico (AERO) is set to continue the trend.The global airline filed last week for a $300 million US IPO that could come as soon as......read more
Updated: Renaissance Capital's 1Q 2024 US IPO Market Review
US IPO Market's Green Shoots Take Root In the first quarter of 2024, the IPO market's green shoots grew further, with 30 IPOs raising a combined $7.8 billion. While deal count was in line with the 1Q23, proceeds more than tripled, thanks to the continued return ...read more
Renaissance Capital's February IPO Market Update
In February, 10 IPOs raised a combined $2.0 billion, led by early debuts from a handful of $100+ million offerings. Deal flow was led by healthcare and senior facilities provider American Healthcare REIT (AHR) and Mexican discount grocer BBB Foods (TBBB),...read more
US IPO Weekly Recap: Autoimmune biotech Kyverna Therapeutics gains 37% in a 6 IPO week
Six IPOs priced this past week, joined by two blank check companies.One larger deal did not get done: Fortegra (TFG) pulled its $297 million offering ahead of its expected pricing. The specialty insurer had previously attempted to go public in early 2021 but...read more